{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:54:38Z","timestamp":1787504078715,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004801","name":"Shota Rustaveli National Science Foundation","doi-asserted-by":"publisher","award":["FR-22-6827"],"award-info":[{"award-number":["FR-22-6827"]}],"id":[{"id":"10.13039\/501100004801","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07492-w","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:44:34Z","timestamp":1759232674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epigenetic functions and biomarker potential of PIWI-interacting RNAs in oncogenesis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1764-7778","authenticated-orcid":false,"given":"Kldiashvili","family":"Ekaterina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiatari","family":"Ivane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kekelia","family":"Elene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iordanishvili","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metreveli","family":"Tornike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dumbadze","family":"Eter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"7492_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu X, Zhao H, Wang R, Chen Y, Quyang X, Li W, Sun W, Peng A. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov. 2024;10:28.","journal-title":"Cell Death Discov"},{"key":"7492_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ejca.2022.10.015","volume":"178","author":"J Ibrahim","year":"2023","unstructured":"Ibrahim J, Peeters M, Van Camp G, de Beeck KO. Methylation biomarkers for early cancer detection and diagnosis: current and future perspectives. EJC. 2023;178:91\u2013113.","journal-title":"EJC"},{"key":"7492_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Sig Transduct Target Ther. 2024;9:132.","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"7492_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-023-01749-3","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhu Y, Cao X, Tan W, Yu J, Lu Y, Kang R, Wang X, Li E. The epigenetic regulatory mechanism of piwi\/pirnas in human cancers. Mol Cancer. 2023;22(1):45.","journal-title":"Mol Cancer"},{"issue":"1","key":"7492_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00018-024-05399-6","volume":"81","author":"L Du","year":"2024","unstructured":"Du L, Chen W, Zhang D, Cui Y, He Z. The functions and mechanisms of PiRNAs in mediating mammalian spermatogenesis and their applications in reproductive medicine. CMLS. 2024;81(1):379.","journal-title":"CMLS"},{"key":"7492_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13059-020-02221-x","volume":"22","author":"C Wang","year":"2021","unstructured":"Wang C, Lin H. Roles of PiRNAs in transposon and pseudogene regulation of germline mRNAs and LncRNAs. Genome Biol. 2021;22:27.","journal-title":"Genome Biol"},{"issue":"1","key":"7492_CR7","first-page":"160","volume":"1871","author":"W Weng","year":"2019","unstructured":"Weng W, Li H, Goel A. Piwi-interacting RNAs (piRNAs) and cancer: emerging biological concepts and potential clinical implications. BBA. 2019;1871(1):160\u20139.","journal-title":"BBA"},{"issue":"1","key":"7492_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-024-00563-3","volume":"12","author":"E Garcia-Borja","year":"2024","unstructured":"Garcia-Borja E, Siegl F, Mateu R, Slaby O, Sedo A, Busek P, Sana J. Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells. Biomark Res. 2024;12(1):15.","journal-title":"Biomark Res"},{"key":"7492_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-023-01749-3","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhu Y, Cao X, Tan W, Yu J, Kang R, Wang X, Li E. The epigenetic regulatory mechanism of piwi\/pirnas in human cancers. Mol Cancer. 2023;22:45.","journal-title":"Mol Cancer"},{"key":"7492_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12964-023-01368-x","volume":"21","author":"Z Wu","year":"2023","unstructured":"Wu Z, Yu X, Zhang S, He Y, Guo W. Novel roles of PIWI proteins and PIWI-interacting RNAs in human health and diseases. Cell Commun Signal. 2023;21:343.","journal-title":"Cell Commun Signal"},{"key":"7492_CR11","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41392-023-01528-y","volume":"8","author":"R Liu","year":"2023","unstructured":"Liu R, Zhao E, Yu H, Yuan C, Abbas MN, Cui H. Methylation across the central dogma in health and diseases: new therapeutic strategies. Sig Transduct Target Ther. 2023;8:310.","journal-title":"Sig Transduct Target Ther"},{"key":"7492_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13148-018-0450-y","volume":"10","author":"E Hervouet","year":"2018","unstructured":"Hervouet E, Peixoto P, Delage-Mourroux R, Boyer-Guittaut M, Cartron PF. Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma. Clin Epigenet. 2018;10:17.","journal-title":"Clin Epigenet"},{"key":"7492_CR13","first-page":"175883592312205","volume":"16","author":"F Geissler","year":"2024","unstructured":"Geissler F, Nesic K, Kondrashova O, Dobrovic A, Swisher EM, Scott CL, Wakefield J M. The role of aberrant DNA methylation in cancer initiation and clinical impacts. TAM. 2024;16:17588359231220511.","journal-title":"TAM"},{"issue":"15","key":"7492_CR14","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.3390\/cancers15153912","volume":"15","author":"S Taverna","year":"2023","unstructured":"Taverna S, Masucci A, Cammarata G. PIWI-RNAs small noncoding RNAs with smart functions: potential theranostic applications in cancer. Cancers. 2023;15(15):3912.","journal-title":"Cancers"},{"issue":"13","key":"7492_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e33767","volume":"10","author":"S Ahmadi Asouri","year":"2024","unstructured":"Ahmadi Asouri S, Aghadavood E, Mirzaei H, Abaspour A, Esmaeil Shahaboddin M. PIWI-interacting RNAs (PiRNAs) as emerging biomarkers and therapeutic targets in biliary tract cancers: a comprehensive review. Heliyon. 2024;10(13):e33767.","journal-title":"Heliyon"},{"key":"7492_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.omtn.2020.05.023","volume":"21","author":"X Wu","year":"2020","unstructured":"Wu X, Pan Y, Fang Y, Zhang J, Xie M, Yang F, Yu T, Ma P, Li W, Shu Y. The biogenesis and functions of PiRNAs in human diseases. Mol Ther Nucleic Acids. 2020;21:108\u201320.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"7492_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13353-013-0173-x","volume":"54","author":"B Kozera","year":"2013","unstructured":"Kozera B, Rapacz M. Reference genes in real-time PCR. J Appl Genet. 2013;54(4):391\u2013406.","journal-title":"J Appl Genet"},{"issue":"4","key":"7492_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2^(-\u2206\u2206Ct) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"key":"7492_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/15257770.2024.2437037","author":"C Oner","year":"2024","unstructured":"Oner C, Koser F, Colak E. The association of piR-651 and piR-823 on metastatic and invasive characteristics of triple negative breast cancer cells. Nucleosides Nucleotides Nucleic Acids. 2024. https:\/\/doi.org\/10.1080\/15257770.2024.2437037","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"1","key":"7492_CR20","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1186\/s12885-024-12180-2","volume":"24","author":"M Taghizadeh","year":"2024","unstructured":"Taghizadeh M, Jafari-Koshki T, Jafarlou V, Raeisi M, Alizadeh L, Roosta Y, Matin S, Jabari R, Sur D, Karimi A. The role of PiRNAs in predicting and prognosing in cancer: a focus on piRNA-823 (a systematic review and meta-analysis). BMC Cancer. 2024;24(1):484.","journal-title":"BMC Cancer"},{"key":"7492_CR21","doi-asserted-by":"publisher","first-page":"641052","DOI":"10.3389\/fcell.2021.641052","volume":"9","author":"X Ding","year":"2021","unstructured":"Ding X, Li Y, L\u00fc J, Zhao Q, Guo Y, Lu Z, Ma W, Liu P, Pestell RG, Liang C, Yu Z. piRNA-823 is involved in cancer stem cell regulation through altering DNA methylation in association with luminal breast cancer. Front Cell Dev Biol. 2021;9:641052.","journal-title":"Front Cell Dev Biol"},{"key":"7492_CR22","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/cas.13300","volume":"108","author":"J Yin","year":"2017","unstructured":"Yin J, Jiang X-Y, Qi W, Ji C-G, Xie X-L, Zhang D-X, Cui Z-J, Wang C-K, Bai Y, Wang J. Jiang H-Q. (2017). piR-823 contributes to colorectal tumorigenesis by enhancing the transcriptional activity of HSF1. 2017;108:1746\u201356.","journal-title":"Cancer Sci"},{"issue":"12","key":"7492_CR23","doi-asserted-by":"publisher","first-page":"e0294685","DOI":"10.1371\/journal.pone.0294685","volume":"18","author":"EJ Sohn","year":"2023","unstructured":"Sohn EJ, Han ME, Park YM, Kim YH, Oh SO. The potential of piR-823 as a diagnostic biomarker in oncology: a systematic review. PLoS ONE. 2023;18(12):e0294685.","journal-title":"PLoS ONE"},{"issue":"16","key":"7492_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1080\/15384101.2021.1956090","volume":"20","author":"T Liu","year":"2021","unstructured":"Liu T, Wang J, Sun L, Li M, He X, Jiang J, Zhou Q. Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation. Cell Cycle (Georgetown Tex). 2021;20(16):1603\u201316.","journal-title":"Cell Cycle (Georgetown Tex)"},{"issue":"44","key":"7492_CR25","doi-asserted-by":"publisher","first-page":"76898","DOI":"10.18632\/oncotarget.20176","volume":"8","author":"CJ Poole","year":"2017","unstructured":"Poole CJ, Zheng W, Lodh A, Yevtodiyenko A, Liefwalker D, Li H, Felsher DW, van Riggelen J. DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and burkitt\u2019s lymphoma. Oncotarget. 2017;8(44):76898\u2013920.","journal-title":"Oncotarget"},{"key":"7492_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40364-017-0081-z","volume":"5","author":"W Zhang","year":"2017","unstructured":"Zhang W, Xu J. DNA methyltransferases and their roles in tumorigenesis. Biomark Res. 2017;5:1.","journal-title":"Biomark Res"},{"key":"7492_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41392-023-01341-7","volume":"8","author":"N Wang","year":"2023","unstructured":"Wang N, Ma T, Yu B. Targeting epigenetic regulators to overcome drug resistance in cancers. Sig Transduct Target Ther. 2023;8:69.","journal-title":"Sig Transduct Target Ther"},{"key":"7492_CR28","first-page":"917","volume":"19","author":"Z Niknami","year":"2020","unstructured":"Niknami Z, Muhammadnejad A, Ebrahimi A, Harsani Z, Shirkoohi R. Significance of E-cadherin and vimentin as epithelial\u2013mesenchymal transition markers in colorectal carcinoma prognosis. EXCLI J. 2020;19:917\u201326.","journal-title":"EXCLI J"},{"key":"7492_CR29","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12885-021-08062-6","volume":"21","author":"B Zhou","year":"2021","unstructured":"Zhou B, Xiang J, Jin M, Zheng Z, Li G, Yan S. High vimentin expression with E-cadherin expression loss predicts a poor prognosis after resection of grade 1 and 2 pancreatic neuroendocrine tumors. BMC Cancer. 2021;21:334.","journal-title":"BMC Cancer"},{"key":"7492_CR30","doi-asserted-by":"publisher","first-page":"943253","DOI":"10.3389\/fonc.2022.943253","volume":"12","author":"E S\u00e1nchez-Herrero","year":"2022","unstructured":"S\u00e1nchez-Herrero E, Serna-Blasco R, Robado de Lope L, Gonz\u00e1lez-Rumayor V, Romero A, Provencio M. Circulating tumor DNA as a cancer biomarker: an overview of biological features and factors that May impact on ctdna analysis. Front Oncol. 2022;12:943253.","journal-title":"Front Oncol"},{"issue":"17","key":"7492_CR31","doi-asserted-by":"publisher","first-page":"13219","DOI":"10.3390\/ijms241713219","volume":"24","author":"J Dao","year":"2023","unstructured":"Dao J, Conway PJ, Subramani B, Meyyappan D, Russell S, Mahadevan D. Using CfDNA and ctdna as oncologic markers: a path to clinical validation. Int J Mol Sci. 2023;24(17):13219.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"7492_CR32","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1373\/clinchem.2005.049320","volume":"51","author":"S Holdenrieder","year":"2005","unstructured":"Holdenrieder S, Stieber P, Chan LYS, Geiger S, Kremer A, Nagel D, Lo YMD. Cell-Free DNA in serum and plasma: comparison of ELISA and quantitative PCR. Clin Chem. 2005;51(8):1544\u20136.","journal-title":"Clin Chem"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07492-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07492-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07492-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:44:46Z","timestamp":1759232686000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07492-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7492"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07492-w","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was secured from the Bioethics International Committee of the Petre Shotadze Tbilisi Medical Academy (IRB20042004\/1, Tbilisi, Georgia). All procedures adhered to the Helsinki Declaration of 1975, revised in 2013, with participants receiving comprehensive study information and providing written informed consent prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"During the preparation of this paper the authors used ChatGPT (\n                      \n                      ) for stylistic purpose, checking grammar and spelling. After using this tool the authors reviewed and edited the content, they take full responsibility for the content of the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted Technologies"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"395"}}